公众号 / 文章胸部心血管CT

肺癌筛查中整合心血管风险评估

Integrating Cardiovascular Screening in Lung Cancer Screening.
PubMed 文献 · Br J Radiol · 2026-08-17

本文探讨在肺癌筛查(LCS)低剂量CT中同步评估心血管风险的可行性与价值。冠状动脉钙化(CAC)可在不增加辐射和检查负担的情况下从同一胸部CT获取,具有预后意义。文章建议以标准化报告、预防路径和前瞻性评估来务实推进整合筛查。

要点

  • 肺癌筛查人群常伴高心血管风险,同一低剂量CT可直接观察冠状动脉钙化。
  • 报告CAC有助于改善风险识别和预防措施使用,与较低心血管死亡率相关。
  • 人工智能可辅助标准化CAC评估并提取更多心血管表型。

核心结论

  • 在肺癌筛查中整合心血管风险评估是自然延伸,同一低剂量CT可在不增加额外影像、辐射或患者负担的情况下提供CAC等心血管信息。
  • 目前尚无前瞻性结局试验证明对LCS中检出的CAC进行干预可减少事件。
  • 一项随机LCS试验的长期随访分析显示,CAC报告与较低心血管死亡率相关,可能反映风险识别改善和预防措施使用增加。

研究设计与样本

  • 本文为叙述性综述或观点性文章,未报告系统检索策略或纳入文献数量。
  • 文章基于已发表肺癌筛查试验长期随访分析和冠状动脉钙化评估方法相关文献进行综合论述。

诊断标准与关键数值

  • CAC可通过视觉、半定量和自动化方法在非门控胸部CT上进行评估。
  • CAC评估结果具有预后价值,可提供超出传统评分的风险信息。
  • 文章未报告敏感度、特异度、AUC、阈值或分级标准的原始数值。

临床应用与阅片要点

  • 整合筛查的实施应务实,包括标准化报告和清晰的预防性医疗路径。
  • 需前瞻性评估治疗启动、依从性、结局、成本效益及潜在意外后果。
  • 放射科医生可在肺癌筛查报告中附加CAC的视觉评估结果,帮助识别高风险个体。

局限性

  • 目前尚无前瞻性结局试验证明对LCS中检出CAC进行干预可减少事件。
  • 文章未报告系统检索策略和纳入文献数量,证据强度难以量化评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Cardiovascular risk assessment is a natural extension of lung cancer screening (LCS) because individuals eligible for low-dose computed tomography often carry a high burden of cardiovascular risk, and cardiovascular disease remains a major competing cause of morbidity and mortality. The same examination can provide clinically relevant cardiovascular information, particularly through coronary artery calcium (CAC) assessment, without additional imaging, radiation exposure, or patient burden. Visual, semi-quantitative, and automated approaches support the prognostic value of CAC detected on non-gated chest computed tomography. No prospective outcome trial has yet shown that intervention on CAC detected during LCS reduces events. However, a long-term follow-up analysis of a randomized LCS trial found that CAC reporting was associated with lower cardiovascular mortality, likely reflecting improved risk recognition and greater use of preventive care. Implementation of simultaneous LCS and CAC screening should therefore be pragmatic, with standardized reporting, clear preventive care pathways, and prospective evaluation of treatment initiation, adherence, outcomes, cost-effectiveness, and potential unintended consequences. Artificial intelligence may help standardize CAC assessment, extract cardiovascular phenotypes beyond conventional scoring, and support integrated thoracic and cardiovascular prevention.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Mozafary, Rezaeifar, Naghavi, et al. Integrating Cardiovascular Screening in Lung Cancer Screening. Br J Radiol. 2026. PMID: 42608820. doi:10.1093/bjr/tqag189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。